Thiamine and benfotiamine prevent apoptosis induced by high glucose‐conditioned extracellular matrix in human retinal pericytes
暂无分享,去创建一个
Elena Berrone | Elena Beltramo | Massimo Porta | M. Porta | Sonia Tarallo | Konstantin Nizheradze | S. Tarallo | K. Nizheradze | E. Beltramo | E. Berrone | Elena Berrone
[1] M. Porta,et al. Effects of thiamine and benfotiamine on intracellular glucose metabolism and relevance in the prevention of diabetic complications , 2008, Acta Diabetologica.
[2] K. Hirschi,et al. Pericytes in the microvasculature. , 1996, Cardiovascular research.
[3] R. Engerman,et al. Pathogenesis of Diabetic Retinopathy , 1989, Diabetes.
[4] F. Pomero,et al. A study of capillary pericyte viability on extracellular matrix produced by endothelial cells in high glucose , 2003, Diabetologia.
[5] B. Safai,et al. Hyperglycemia activates p53 and p53-regulated genes leading to myocyte cell death. , 2001, Diabetes.
[6] A. Reddi. Collagen metabolism in the retina of normal and diabetic rats. , 1985, Experimental eye research.
[7] Elena Berrone,et al. Regulation of Intracellular Glucose and Polyol Pathway by Thiamine and Benfotiamine in Vascular Cells Cultured in High Glucose* , 2006, Journal of Biological Chemistry.
[8] F. Pomero,et al. Pericyte adhesion is impaired on extracellular matrix produced by endothelial cells in high hexose concentrations , 2002, Diabetologia.
[9] M. Porta,et al. Dehydroepiandrosterone protects bovine retinal capillary pericytes against glucose toxicity. , 1998, The Journal of endocrinology.
[10] H. Hammes,et al. Establishment and characterization of a human retinal pericyte line: a novel tool for the study of diabetic retinopathy. , 2009, International journal of molecular medicine.
[11] E. Cagliero,et al. Characteristics and Mechanisms of High-Glucose–Induced Overexpression of Basement Membrane Components in Cultured Human Endothelial Cells , 1991, Diabetes.
[12] Paul J Thornalley,et al. High-dose thiamine therapy for patients with type 2 diabetes and microalbuminuria: a randomised, double-blind placebo-controlled pilot study , 2009, Diabetologia.
[13] Elena Berrone,et al. Different apoptotic responses of human and bovine pericytes to fluctuating glucose levels and protective role of thiamine , 2009, Diabetes/metabolism research and reviews.
[14] C. Betsholtz,et al. Endothelial/Pericyte Interactions , 2005, Circulation research.
[15] Paul J Thornalley,et al. Kinetics and mechanism of the reaction of aminoguanidine with the alpha-oxoaldehydes glyoxal, methylglyoxal, and 3-deoxyglucosone under physiological conditions. , 2000, Biochemical pharmacology.
[16] Y. A. Minamishima,et al. ASC is a Bax adaptor and regulates the p53–Bax mitochondrial apoptosis pathway , 2004, Nature Cell Biology.
[17] R. Poulsom,et al. Increased steady-state levels of laminin B1 mRNA in kidneys of long-term streptozotocin-diabetic rats. No effect of an aldose reductase inhibitor. , 1988, The Journal of biological chemistry.
[18] T. Kern,et al. Comparison of retinal lesions in alloxan-diabetic rats and galactose-fed rats. , 1994, Current eye research.
[19] Dawn G. Smith,et al. Glyoxalase I Is Critical for Human Retinal Capillary Pericyte Survival under Hyperglycemic Conditions* , 2006, Journal of Biological Chemistry.
[20] D. Noonan,et al. Altered Steady-State mRNA Levels of Basement Membrane Proteins in Diabetic Mouse Kidneys and Thromboxane Synthase Inhibition , 1990, Diabetes.
[21] B. Chaqour,et al. Matrix Metalloproteinase‐2 Expression and Apoptogenic Activity in Retinal Pericytes , 2007, Annals of the New York Academy of Sciences.
[22] D. Cogan,et al. The mural cell in perspective. , 1967, Archives of ophthalmology.
[23] D. Allen,et al. Mechanisms of high glucose-induced apoptosis and its relationship to diabetic complications. , 2005, The Journal of nutritional biochemistry.
[24] E. Dejuan,et al. Human diabetic neovascular membranes contain high levels of urokinase and metalloproteinase enzymes. , 1999, Investigative ophthalmology & visual science.
[25] Alan W. Stitt,et al. Inhibition of platelet-derived growth factor promotes pericyte loss and angiogenesis in ischemic retinopathy. , 2004, The American journal of pathology.
[26] N. Ahmed,et al. Glycation and diabetic complications. , 1991, JPMA. The Journal of the Pakistan Medical Association.
[27] C. Kilo,et al. Basement membrane abnormalities in diabetes mellitus: relationship to clinical microangiopathy. , 1988, Diabetes/metabolism reviews.
[28] A. Barden,et al. Advanced Glycation End Products: A Review , 2013 .
[29] W. R. Hatrick. On Diabetes , 1862, Glasgow medical journal.
[30] M. Porta,et al. Thiamine corrects delayed replication and decreases production of lactate and advanced glycation end-products in bovine retinal and human umbilical vein endothelial cells cultured under high glucose conditions , 1996, Diabetologia.
[31] Timothy S Kern,et al. Activation of nuclear factor-kappaB induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes. , 2002, Diabetes.
[32] M. Siperstein. Diabetic microangiopathy, genetics, environment, and treatment. , 1988, The American journal of medicine.
[33] Y. Taniyama,et al. Hepatocyte growth factor prevents endothelial cell death through inhibition of bax translocation from cytosol to mitochondrial membrane. , 2002, Diabetes.
[34] R. G. Paul,et al. The effect of advanced glycation end-product formation upon cell-matrix interactions. , 1999, The international journal of biochemistry & cell biology.
[35] H. Hammes,et al. Pericytes and the Pathogenesis of Diabetic Retinopathy , 2005, Diabetes.
[36] M. Stepp,et al. Integrin overexpression induced by high glucose and by human diabetes: potential pathway to cell dysfunction in diabetic microangiopathy. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[37] D. Yue,et al. High glucose alters matrix metalloproteinase expression in two key vascular cells: potential impact on atherosclerosis in diabetes. , 2003, Atherosclerosis.
[38] H. Hammes,et al. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy , 2003, Nature Medicine.
[39] B. Chaqour,et al. Matrix metalloproteinase-2 expression and apoptogenic activity in retinal pericytes: implications in diabetic retinopathy. , 2007, Annals of the New York Academy of Sciences.
[40] Paul J Thornalley,et al. Increased Dicarbonyl Metabolism in Endothelial Cells in Hyperglycemia Induces Anoikis and Impairs Angiogenesis by RGD and GFOGER Motif Modification , 2006, Diabetes.
[41] E. Cagliero,et al. Cytoskeletal changes induced by excess extracellular matrix impair endothelial cell replication , 1997, Diabetologia.
[42] John Calvin Reed,et al. Bax is increased in the retina of diabetic subjects and is associated with pericyte apoptosis in vivo and in vitro. , 2000, The American journal of pathology.
[43] Paul J Thornalley,et al. High-dose thiamine therapy counters dyslipidaemia in streptozotocin-induced diabetic rats , 2004, Diabetologia.
[44] R. Engerman,et al. Cell turnover of capillaries. , 1967, Laboratory investigation; a journal of technical methods and pathology.
[45] J. D. Bradley,et al. Differential effects of heparin, fibronectin, and laminin on the phosphorylation of basic fibroblast growth factor by protein kinase C and the catalytic subunit of protein kinase A , 1989, The Journal of cell biology.
[46] S. Cory,et al. The Bcl-2 protein family: arbiters of cell survival. , 1998, Science.
[47] E. Cagliero,et al. Increased expression of basement membrane components in human endothelial cells cultured in high glucose. , 1988, The Journal of clinical investigation.
[48] E. Cagliero,et al. Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[49] M. Porta,et al. Thiamine and benfotiamine prevent increased apoptosis in endothelial cells and pericytes cultured in high glucose , 2004, Diabetes/metabolism research and reviews.
[50] M. Brownlee,et al. Glomerular Basement Membrane Metabolism in the Diabetic Rat: In Vivo Studies , 1979, Diabetes.